PHACA_EMEND
ID PHACA_EMEND Reviewed; 518 AA.
AC Q9Y7G5; Q5AUF2;
DT 05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1999, sequence version 1.
DT 03-AUG-2022, entry version 114.
DE RecName: Full=Phenylacetate 2-hydroxylase;
DE EC=1.14.14.54 {ECO:0000269|PubMed:10329644};
GN Name=phacA;
OS Emericella nidulans (Aspergillus nidulans).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC Aspergillus subgen. Nidulantes.
OX NCBI_TaxID=162425;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], CATALYTIC ACTIVITY, FUNCTION, INDUCTION,
RP AND DISRUPTION PHENOTYPE.
RC STRAIN=biA1;
RX PubMed=10329644; DOI=10.1074/jbc.274.21.14545;
RA Mingot J.M., Penalva M.A., Fernandez-Canon J.M.;
RT "Disruption of phacA, an Aspergillus nidulans gene encoding a novel
RT cytochrome P450 monooxygenase catalyzing phenylacetate 2-hydroxylation,
RT results in penicillin overproduction.";
RL J. Biol. Chem. 274:14545-14550(1999).
CC -!- FUNCTION: Catalyzes the hydroxylation of phenylacetate to 2-
CC hydroxyphenylacetate in the homogentisate pathway. The homogentisate
CC pathway is used to catabolize phenylacetate and use it as a carbon
CC source. Can also catalyze the hydroxylation of 3-hydroxyphenylacetate
CC to 2,5-dihydroxyphenylacetate (homogentisate) at low efficiency.
CC {ECO:0000269|PubMed:10329644}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=2-phenylacetate + O2 + reduced [NADPH--hemoprotein reductase]
CC = (2-hydroxyphenyl)acetate + H(+) + H2O + oxidized [NADPH--
CC hemoprotein reductase]; Xref=Rhea:RHEA:53392, Rhea:RHEA-COMP:11964,
CC Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:15379, ChEBI:CHEBI:18401, ChEBI:CHEBI:57618,
CC ChEBI:CHEBI:58210, ChEBI:CHEBI:62423; EC=1.14.14.54;
CC Evidence={ECO:0000269|PubMed:10329644};
CC -!- PATHWAY: Aromatic compound metabolism; phenylacetate degradation.
CC -!- INDUCTION: Induced by phenylacetate. {ECO:0000269|PubMed:10329644}.
CC -!- DISRUPTION PHENOTYPE: Increases penicillin production, probably by
CC relieving the competition for the precursor phenylacetate by the
CC catabolic homogentisate pathway and the penicillin biosynthetic
CC pathway. {ECO:0000269|PubMed:10329644}.
CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AJ132442; CAB43093.1; -; Genomic_DNA.
DR AlphaFoldDB; Q9Y7G5; -.
DR SMR; Q9Y7G5; -.
DR OMA; NYGFRIE; -.
DR BRENDA; 1.14.14.54; 517.
DR UniPathway; UPA00930; -.
DR GO; GO:0020037; F:heme binding; IEA:InterPro.
DR GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR GO; GO:0018631; F:phenylacetate hydroxylase activity; IMP:AspGD.
DR GO; GO:0042318; P:penicillin biosynthetic process; IMP:AspGD.
DR GO; GO:0010124; P:phenylacetate catabolic process; IMP:AspGD.
DR Gene3D; 1.10.630.10; -; 1.
DR InterPro; IPR001128; Cyt_P450.
DR InterPro; IPR002401; Cyt_P450_E_grp-I.
DR InterPro; IPR036396; Cyt_P450_sf.
DR Pfam; PF00067; p450; 1.
DR PRINTS; PR00463; EP450I.
DR PRINTS; PR00385; P450.
DR SUPFAM; SSF48264; SSF48264; 1.
PE 1: Evidence at protein level;
KW Heme; Iron; Metal-binding; Monooxygenase; NAD; Oxidoreductase.
FT CHAIN 1..518
FT /note="Phenylacetate 2-hydroxylase"
FT /id="PRO_0000418444"
FT BINDING 437
FT /ligand="heme"
FT /ligand_id="ChEBI:CHEBI:30413"
FT /ligand_part="Fe"
FT /ligand_part_id="ChEBI:CHEBI:18248"
FT /note="axial binding residue"
FT /evidence="ECO:0000250"
SQ SEQUENCE 518 AA; 58495 MW; 9B5387AA59859A71 CRC64;
MSLQTIGIAA VAVVYFLIRY FNRTDIPKIK GLPEVPGVPI FGNLIQLGDQ HATVAQKWAK
KFGPVFQVRM GNKRVVFANT FDSVRQLWIK DQSALISRPT FHTFHSVVSS SQGFTIGTSP
WDESCKRRRK AAATALNRPA TQSYMPIIDL ESMSSIRELL RDSANGTMDI NPTAYFQRFA
LNTSLTLNYG IRIEGNVNDE LLREIVDVER GVSNFRSTSN QWQDYIPLLR IFPKMNREAE
EFRVRRDKYL TYLLDVLKDR IAKGTDKPCI TGNILKDPEA KLNDAEIKSI CLTMVSAGLD
TVPGNLIMGI AYLASEDGQR IQKRAHDEIM KVYPDGDAWE KCLLEEKVPY VTALVKETLR
FWTVIPICLP RENTKDIVWN GAVIPKGTTF FMNAYAADYD ETHFTNPHAF EPERYLTASS
DGSGTPHYGY GAGSRMCAGS HLANRELFTA YVRLITAFTM HPAKRAEDRP ILDAIECNAI
PTALTTEPKP FKVGFKPRDP VLVRKWIAES EERTKHLN